23andMe Investor Presentation Deck

Health Predispositions¹ 30+ Including: Type 2 Diabetes (Powered by 23andMe Research) Coronary Artery Disease 23 andMe+ Uterine Fibroids 23andMe+ Migraine 23andMe+ MUTYH-Associated Polyposis BRCA1/BRCA2 (selected variants) Type 2 Diabetes YOUR RESULT Our Health Service The First and Only Multi-Disease DTC Personal Genome Service (PGS) That Includes FDA-Authorized Reports and Provides Personalized Genetic Insights and Tools Your genetics are associated with a typical likelihood. XX 37% Wellness² 10 Including: Muscle Composition Genetic Weight Alcohol Flush Reaction Saturated Fat and Weight Sleep Movement Dog & Cat Allergies 23andMe+ Genetic Weight YOUR FEE Your genes predispose you to weigh about 7% less than average. Avign 142 Carrier Status 40+ Including: Cystic Fibrosis Sickle Cell Anemia Familial Hyperinsulinism (ABCC8-Related) Tay-Sachs Disease Glycogen Storage Disease (Type 1a) Chrome Tay-Sachs Disease YOUR RESULT You do not have the variants we tested. 0 variants detected 1. Includes FDA Authorized Genetic Health Risk Reports and Wellness Reports for Genetic Likelihood Powered by 23and Me Research. 2. Wellness information does not require FDA Authorization. Pharmacogenetics 3 Including: SLC01B1 Drug Transport CYP2C19 Drug Metabolism DPYD Drug Metabolism e.g., citalopram and clopidogrel Copyright © 2022 23and Me, Inc. Pharmacogenetics Genetic variants may influence how you process medications. YOUR PESULTS CYP2C19 Drug Metabolism LIKELY NORMAL METABOLIZER DPYD Drug Metabolism LIKELY NORMAL METABOLIZER SLC01B1 Drug Transport LIKELY NORMAL FUNCTION Print summary 7 FDA Authorizations > 23andMe+ 23andMe 15

View entire presentation